
CAS Number145-13-1
SynonymsEINECS 205-647-4; prenolon; ZK-5553; MFCD00003628; prenenolone; Pregnelone; Pregnenlolone; 3-Hydroxypregn-5-en-20-one; Pregnenolone; 3β-Hydroxy-5-pregnen-20-one; 5-Pregnen-3β-ol-20-one; pregnolon; Progeserone
Molecular FormulaC21H32O2
Molecular Weight316.48
Purity≥98%
Density1.1±0.1 g/cm3
Boiling Point443.3±45.0 °C at 760 mmHg
Melting Point188-190 °C
Appearancepowder
EINECS205-647-4
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 145-13-1 |
| Catalog No. | 2A-9008693 |
| Chinese Name | 孕烯醇酮 |
| Synonyms | EINECS 205-647-4; prenolon; ZK-5553; MFCD00003628; prenenolone; Pregnelone; Pregnenlolone; 3-Hydroxypregn-5-en-20-one; Pregnenolone; 3β-Hydroxy-5-pregnen-20-one; 5-Pregnen-3β-ol-20-one; pregnolon; Progeserone |
| Molecular Formula | C21H32O2 |
| Molecular Weight | 316.48 |
| Purity | ≥98 |
| Density | 1.1±0.1 g/cm3 |
| Boiling Point | 443.3±45.0 °C at 760 mmHg |
| Melting Point | 188-190 °C |
| Appearance | powder |
| Water Solubility | Water solubility: Practically insoluble; soluble i |
| Storage Condition | Store in a dry and cool place. |
| Packaging | Foil bag |
| Application | Pregnenolone is a specific inhibitor of the cannabinoid CB1 receptor. |
| EINECS | 205-647-4 |
| HTC | 2937290090 |
| PubChem ID | 24899008 |
| MDL Number | MFCD00003628 |
| SMILES | [H][C@@]12CC=C3C[C@@H](O)CC[C@]3(C)[C@@]1([H])CC[C@]4(C)[C@H](CC[C@@]24[H])C(C)=O |
| InChI | 1S/C21H32O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4,15-19,23H,5-12H2,1-3H3/t15-,16-,17+,18-,19-,20-,21+/m0/s1 |
| InChI Key | ORNBQBCIOKFOEO-QGVNFLHTSA-N |
| Beilstein/REAXYS | 2059026 |
| NACRES Code | NA.77 |
| UNSPSC | 12352211 |
| Safety Description | S24/25 |
| MSDS | msds/8693_2_145_13_1.pdf |
| Bioactivity | Pregnenolone acts as a signaling-specific inhibitor of cannabinoid CB1 receptor, reduces several effects of tetrahydrocannabinol (THC). Related Catalog Signaling Pathways >> Autophagy >> Autophagy Signaling Pathways >> GPCR/G Protein >> Cannabinoid Receptor Research Areas >> Neurological Disease Natural Products >> Steroids Target CB1 Receptor Human Endogenous Metabolite In Vitro The effect of THC is significantly attenuated when slices are pre-treated with Pregnenolone 100 nM (15.1±1.8 % of inhibition). These effects are likely due to a pre-synaptic action of Pregnenolone. Thus, Pregnenolone blocks the increase in paired-pulse ratio (PPR) induced by THC but does not modify either the amplitude or the decay time of miniature EPSC (mEPSC)[1]. In Vivo Pregnenolone administration (2-6 mg/kg) blocks THC-induced food-intake in Wistar rats and in C57BL/6N mice, and blunts the memory impairment induced by THC in mice, but it does not modify these behaviors per se. Injections of Pregnenolone (2 and 4mg/kg) before each self-administration session reduce the intake of WIN 55,212-2 and reduce the break-point in a progressive ratio schedule[1]. Animal Admin Mice and Rats[1] Adult male Wistar rats (weighing 320-340g), Sprague Dawley male rats (weighing 330-350g), C57BL/6N mice (2-3 months) and CD1 mice (weighing 25-30 g at the beginning of the experiments) are used. Pregnenolone is injected subcutaneously (sc). The injection volumes are 1 mL/kg of body weight for rats and 10 mL/kg for mice[1]. References [1]. Vallée M, et al. Pregnenolone can protect the brain from cannabis intoxication. Science. 2014 Jan 3;343(6166):94-8. Chemical & Physical Properties Density 1.1±0.1 g/cm3 Boiling Point 443.3±45.0 °C at 760 mmHg Melting Point 188-190 °C Molecular Formula C21H32O2 Molecular Weight 316.478 Flash Point 188.9±21.3 °C Exact Mass 316.240234 PSA 37.30000 LogP 4.52 Vapour Pressure 0.0±2.4 mmHg at 25°C Index of Refraction 1.550 InChIKey ORNBQBCIOKFOEO-UHFFFAOYSA-N SMILES CC(=O)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C Storage condition 2~8℃ |
| Use of | Pregnenolone acts as a signaling-specific inhibitor of cannabinoid CB1 receptor, reduces several effects of tetrahydrocannabinol (THC). Properties Articles92 Name pregnenolone Synonym More Synonyms Pregnenolone Biological Activity Description Pregnenolone acts as a signaling-specific inhibitor of cannabinoid CB1 receptor, reduces several effects of tetrahydrocannabinol (THC). Related Catalog Signaling Pathways >> Autophagy >> Autophagy Signaling Pathways >> GPCR/G Protein >> Cannabinoid Receptor Research Areas >> Neurological Disease Natural Products >> Steroids CB1 Receptor Human Endogenous Metabolite References [1]. Vallée M, et al. Pregnenolone can protect the brain from cannabis intoxication. Science. 2014 Jan 3;343(6166):94-8. Chemical & Physical Properties Molecular Formula C21H32O2 Exact Mass 316.240234 PSA 37.30000 Index of Refraction 1.550 InChIKey ORNBQBCIOKFOEO-UHFFFAOYSA-N Storage condition 2~8℃ |
| Transport Info | Product name: Purity: 98.0% |
| MSDS Transport Info | Module 14. Shipping information United Nations classification: inconsistent with United Nations classification standards UN number: not specified |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| PolymaleicacidAq | 26099-09-2 | 2A-9008686 |
| Potassium 2-ethylhexanoate | 3164-85-0 | 2A-0201196 |
| Potassium 4-bromobenzenesulfonate | 66788-58-7 | 2A-9008688 |
| Potassium D-(-)-N-(1-methoxycarbonylpropen-2-yl)amino-4-hydroxyphenylacetate | 69416-61-1 | 2A-9008689 |
| Potassium ethoxide | 917-58-8 | 2A-0201937 |
| Pregnenolone acetate | 1778-02-5 | 2A-9008694 |
| Promethazine hydrochloride | 58-33-3 | 2A-9008696 |
| Propyl vinyl ether | 764-47-6 | 2A-9008698 |
| Propylmalonic acid | 14636-95-4 | 2A-9008699 |
| Propylpyridinium bromide | 873-71-2 | 2A-9008700 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA